Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via<i>TLR7</i>

Wei He(Cancer Genetics (United States)), Federica Calore(Cancer Genetics (United States)), Priya Londhe(Cancer Genetics (United States)), Alessandro Canella(Cancer Genetics (United States)), Denis C. Guttridge(Cancer Genetics (United States)), Carlo M. Croce(Cancer Genetics (United States))
Proceedings of the National Academy of Sciences
March 10, 2014
Cited by 247Open Access
Full Text

Abstract

MicroRNAs (miRNAs) are small, noncoding RNAs that regulate gene expression and, in cancers, are often packaged within secreted microvesicles. The cachexia syndrome is a debilitating state of cancer that predominantly results from the loss of skeletal muscle mass, which is in part associated with apoptosis. How tumors promote apoptosis in distally located skeletal muscles has not been explored. Using both tumor cell lines and patient samples, we show that tumor-derived microvesicles induce apoptosis of skeletal muscle cells. This proapoptotic activity is mediated by a microRNA cargo, miR-21, which signals through the Toll-like 7 receptor (TLR7) on murine myoblasts to promote cell death. Furthermore, tumor microvesicles and miR-21 require c-Jun N-terminal kinase activity to regulate this apoptotic response. Together, these results describe a unique pathway by which tumor cells promote muscle loss, which might provide a great insight into elucidating the causes and treatment options of cancer cachexia.


Related Papers

No related papers found

Powered by citation graph analysis